Question

Difficulty: MediumStudy Design

Match each of the following clinical investigation objectives with the epidemiological study design that is optimally suited to address it.

  • Determining the current prevalence of unrecognized chronic kidney disease within a specific metropolitan area during a single calendar year.Cross-sectional study
  • Identifying potential past environmental exposures associated with the development of an exceedingly rare, newly identified neurodegenerative disorder.Case-control study
  • Measuring the 15-year incidence of hepatocellular carcinoma by enrolling healthy volunteers, classifying them by baseline alcohol consumption, and tracking their outcomes.Prospective cohort study
  • Evaluating whether a novel biologic agent is clinically superior to standard-of-care therapy for maintaining remission in patients with moderate-to-severe Crohn disease.Randomized controlled trial

Answer

The correct pairings are: prevalence determination with cross-sectional study, rare disease etiology with case-control study, long-term incidence measurement with prospective cohort study, and therapeutic efficacy evaluation with randomized controlled trial.
Each study design is optimally matched to its distinct methodological strength. Cross-sectional studies provide prevalence data. Case-control studies are highly efficient for rare diseases because they secure a sufficient number of cases upfront. Prospective cohort studies are best for establishing incidence and temporal relationships between exposure and disease. Randomized controlled trials minimize confounding to definitively assess treatment efficacy.

Step-by-Step Solution

1
Analyze the temporal direction and primary goal of each research scenario.
Identified whether the study looks forward in time, backward in time, acts at a single point, or involves active intervention.
Temporal direction and investigator involvement are the primary differentiating factors between major epidemiological study designs.
2
Match the prevalence scenario.
Paired the single calendar year prevalence study with the cross-sectional design.
Cross-sectional studies are a 'snapshot' in time used to measure prevalence.
3
Match the rare disease scenario.
Paired the rare neurodegenerative disorder investigation with the case-control design.
Rare outcomes require case-control designs to ensure enough statistical power without needing massive, unfeasible sample sizes.
4
Match the incidence scenario.
Paired the 15-year tracking of healthy volunteers based on alcohol use with the prospective cohort design.
Tracking exposure groups forward in time to measure new disease development defines a prospective cohort.
5
Match the therapeutic comparison scenario.
Paired the biologic agent versus standard care evaluation with the randomized controlled trial.
Testing a novel therapeutic agent's superiority requires an experimental design with randomization to control for confounding variables.

Key Concept

Selection of epidemiological study designs based on research objectives, disease rarity, and temporal relationships.
Estimated Time:1m 30s
Rate this question